Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f157c4d591acbc4ca05876ab2987ebe2 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-96455 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B10-0283 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2010-008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2021-7723 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4381 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-418 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B10-0241 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B10-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-77 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B10-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
filingDate |
2006-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a3929c24398bc2f89d863b78ea2b2e2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0463393443d86aa0409e79901269de4f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0347ead53a7e2184cb9ce91fbdd176e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ecb677fbeac16eaa9b2ce682d4d026e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9769efb20b64f9e41b84af7991b180da http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_160b3e1462033de5c26b106f5b9bb5dd |
publicationDate |
2006-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1724579-A2 |
titleOfInvention |
Methods of prostate cancer diagnosis and prostate tumour analysis |
abstract |
The invention relates to a method of diagnosing prostate cancer in a subject, which method comprises determining the concentration of a relevant biochemical marker in the periprostatic tissue or lymph nodes of said subject, also to methods which categorise a prostate tumour and/or identify a prostate tumour which has extended beyond the prostatic capsule; as well as to apparatus which is suitable for use in such methods. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9320501-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011033008-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2950242-A1 |
priorityDate |
2005-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |